Vaccines, blood, antisera, toxins and cultures in   Libya

Exports In 2022, Libya exported $4.25k in Vaccines, blood, antisera, toxins and cultures, making it the 172nd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 209th most exported product in Libya. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Libya are: France ($3.81k), Poland ($440), and Ireland ($1).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Libya between 2021 and 2022 were Poland ($440) and Ireland ($1).

Imports In 2022, Libya imported $97.4M in Vaccines, blood, antisera, toxins and cultures, becoming the 100th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 35th most imported product in Libya. Libya imports Vaccines, blood, antisera, toxins and cultures primarily from: France ($26.1M), Switzerland ($24.9M), Germany ($19.3M), Belgium ($11.6M), and United States ($5.57M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Libya between 2021 and 2022 were Belgium ($1.41M), Spain ($468k), and Jordan ($268k).